Business Autoimmune Syndrome (BAS) - Why Building Organizational Defenses Against Change Kills Growth

This paper introduces Business Autoimmune Syndrome (BAS): a condition in which an organisation's protective mechanisms — approval chains, precedent, control functions, and political culture — lose the ability to distinguish genuine risk from healthy change, and begin attacking the organisation's own capacity to adapt. The paper describes how the syndrome accumulates through individually reasonable decisions, why it is structurally hostile to growth, and whom it actually serves: managers whose authority rests on mastery of the existing system. It identifies a distinctive presentation in which the trigger for the immune response is not failure but success — the quiet resource starvation of high-performing work that has become visible above its sponsor's head — and examines organisational negativity and politics as the chronic inflammation of the corporate body. Documented cases (Kodak, Xerox PARC, Nokia, Sony, Blockbuster) and a first-hand case are analysed through the autoimmune lens. The paper closes with a six-part treatment protocol: converting governance from rejection to regulation, armouring sponsorship, inverting managerial incentives, repairing information flow, running periodic autoimmune audits, and treating politics as conduct rather than personality.